nad has been researched along with atovaquone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knecht, W; Löffler, M | 1 |
| Ayuso, JM; Barroilhet, L; Beebe, D; Felder, M; Kapur, A; Kumari, S; Patankar, MS; Rehman, S; Skala, MC; Stenerson, Z | 1 |
2 other study(ies) available for nad and atovaquone
| Article | Year |
|---|---|
Redoxal as a new lead structure for dihydroorotate dehydrogenase inhibitors: a kinetic study of the inhibition mechanism.
Topics: Aminobiphenyl Compounds; Animals; Atovaquone; Dihydroorotate Dehydrogenase; Drug Design; Electron Transport; Humans; Inhibitory Concentration 50; Kinetics; Mitochondria, Liver; NAD; Naphthoquinones; Orotic Acid; Oxidation-Reduction; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Rats; Succinic Acid | 2000 |
Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells.
Topics: Antimalarials; Antineoplastic Agents; Atovaquone; Cell Proliferation; Curcumin; Endometriosis; Female; Humans; NAD; Oxidative Phosphorylation | 2023 |